HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C Stephen Foster Selected Research

prednisolone acetate

1/2020Iontophoretic Dexamethasone Phosphate Compared to Topical Prednisolone Acetate 1% for Noninfectious Anterior Segment Uveitis.
1/2019Difluprednate 0.05% versus Prednisolone Acetate 1% for Endogenous Anterior Uveitis: Pooled Efficacy Analysis of Two Phase 3 Studies.
1/2019Novel Dexamethasone Sodium Phosphate Treatment (DSP-Visulex) for Noninfectious Anterior Uveitis: A Randomized Phase I/II Clinical Trial.
5/2014Difluprednate 0.05% versus prednisolone acetate 1% for endogenous anterior uveitis: a phase III, multicenter, randomized study.
10/2010Durezol (Difluprednate Ophthalmic Emulsion 0.05%) compared with Pred Forte 1% ophthalmic suspension in the treatment of endogenous anterior uveitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


C Stephen Foster Research Topics

Disease

86Inflammation (Inflammations)
01/2022 - 01/2002
71Uveitis
03/2022 - 01/2002
24Scleritis (Episcleritis)
01/2022 - 09/2002
18Benign Mucous Membrane Pemphigoid (Cicatricial Pemphigoid)
01/2019 - 07/2002
17Cataract (Cataracts)
01/2022 - 02/2002
14Anterior Uveitis
01/2022 - 01/2005
13Macular Edema
10/2019 - 08/2002
12Birdshot Chorioretinopathy
01/2022 - 08/2002
12Glaucoma
02/2018 - 02/2002
12Bullous Pemphigoid (Pemphigoid)
11/2013 - 03/2002
11Intermediate Uveitis (Chronic Cyclitis)
05/2017 - 04/2005
10Posterior Uveitis
01/2019 - 09/2004
10Panuveitis
03/2016 - 02/2002
9Disease Progression
08/2020 - 01/2002
8Autoimmune Diseases (Autoimmune Disease)
01/2020 - 07/2002
7Retinal Vasculitis
03/2022 - 11/2006
6Necrosis
07/2021 - 06/2007
6Neoplasms (Cancer)
12/2020 - 01/2008
6Stevens-Johnson Syndrome (Lyell's Syndrome)
06/2017 - 01/2005
6Cicatrix (Scar)
11/2007 - 03/2003
5Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
01/2019 - 02/2008
5Eye Diseases (Eye Disease)
11/2014 - 05/2002
5Vasculitis (Vasculitides)
01/2014 - 06/2006
5Fibrosis (Cirrhosis)
07/2004 - 08/2002
4Keratoconjunctivitis
01/2022 - 03/2007
4Infections
05/2021 - 01/2002
4Papilledema
03/2021 - 08/2002
4White Dot Syndromes
03/2021 - 08/2002
4Pain (Aches)
01/2019 - 03/2007
4Epiretinal Membrane (Epiretinal Membranes)
01/2017 - 08/2002
4Retinal Detachment (Retinal Detachments)
03/2016 - 06/2005
4Drug-Related Side Effects and Adverse Reactions
06/2012 - 01/2002
3Rheumatoid Arthritis
01/2022 - 09/2002
3Juvenile Arthritis (Juvenile Idiopathic Arthritis)
01/2021 - 09/2005
3Leukopenia
01/2019 - 01/2002
3Intraocular Lymphoma
01/2018 - 02/2003
3Lymphoma (Lymphomas)
01/2014 - 08/2005
3Blindness (Hysterical Blindness)
05/2010 - 12/2003

Drug/Important Bio-Agent (IBA)

51Adrenal Cortex Hormones (Corticosteroids)IBA
01/2022 - 01/2002
25SteroidsIBA
10/2020 - 02/2002
15Prednisone (Sone)FDA LinkGeneric
03/2021 - 01/2002
13Immunosuppressive Agents (Immunosuppressants)IBA
01/2018 - 08/2002
13Pharmaceutical PreparationsIBA
06/2017 - 01/2002
12Retinaldehyde (Retinal)IBA
07/2021 - 08/2002
12Methotrexate (Mexate)FDA LinkGeneric
12/2020 - 02/2003
12Infliximab (Remicade)FDA Link
10/2020 - 03/2007
11Fluorescein (Funduscein)FDA LinkGeneric
01/2022 - 02/2008
11Intravenous Immunoglobulins (IVIG)FDA Link
10/2021 - 06/2004
11Rituximab (Mabthera)FDA Link
01/2019 - 12/2009
9Biological ProductsIBA
10/2017 - 01/2012
9Mycophenolic Acid (Cellcept)FDA LinkGeneric
05/2013 - 05/2003
8CollagenIBA
07/2021 - 09/2002
7Alkylating AgentsIBA
01/2017 - 08/2002
7Matrix Metalloproteinases (MMPs)IBA
01/2014 - 03/2003
6CytokinesIBA
01/2022 - 07/2002
6Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2019 - 12/2005
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2016 - 07/2002
6Immunomodulating AgentsIBA
01/2012 - 02/2002
6Daclizumab (Zenapax)FDA Link
05/2009 - 10/2004
5Interleukin-6 (Interleukin 6)IBA
02/2022 - 07/2002
5Dexamethasone (Maxidex)FDA LinkGeneric
03/2021 - 05/2011
5Bevacizumab (Avastin)FDA Link
12/2020 - 08/2007
5prednisolone acetateFDA LinkGeneric
01/2020 - 10/2010
5Fluocinolone Acetonide (Capex)FDA LinkGeneric
01/2019 - 06/2013
5Adalimumab (Humira)FDA Link
01/2019 - 10/2007
5Cyclosporine (Ciclosporin)FDA LinkGeneric
05/2013 - 03/2007
4Indocyanine Green (Cardio-Green)FDA LinkGeneric
01/2022 - 03/2013
4salicylhydroxamic acid (SHAM)IBA
01/2019 - 05/2011
4AntimetabolitesIBA
01/2017 - 01/2008
4Transforming Growth Factor beta1 (TGF beta 1)IBA
10/2004 - 03/2003
3HLA-B27 Antigen (HLA B27 Antigen)IBA
01/2022 - 12/2003
3Acyclovir (Aciclovir)FDA LinkGeneric
01/2022 - 11/2009
3Chlorambucil (Leukeran)FDA Link
03/2021 - 01/2002
3EnzymesIBA
10/2020 - 03/2003
3Ophthalmic Solutions (Eye Drops)IBA
01/2020 - 10/2010
3Immunologic Factors (Immunomodulators)IBA
12/2019 - 10/2007
3Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
10/2019 - 04/2005
3difluprednateFDA Link
01/2019 - 10/2010
3Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2018 - 02/2008
3Interleukin-17 (Interleukin 17)IBA
09/2016 - 10/2010
3Indicators and Reagents (Reagents)IBA
09/2016 - 08/2002
3Interleukin-5 (Interleukin 5)IBA
09/2016 - 07/2002
3AntigensIBA
08/2016 - 10/2005
3Capsules (Microcapsules)IBA
01/2014 - 10/2002
3AntibodiesIBA
11/2013 - 11/2004
3HLA Antigens (Human Leukocyte Antigens)IBA
09/2013 - 02/2003
3Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2012 - 01/2005

Therapy/Procedure

82Therapeutics
01/2022 - 09/2002
36Immunomodulation
03/2022 - 02/2002
8Vitrectomy
01/2017 - 09/2004
5Intraocular Lens Implantation
10/2020 - 10/2002
5Intravitreal Injections
12/2019 - 04/2005
4Transplantation
01/2022 - 05/2002
4Cataract Extraction
07/2021 - 10/2002
4Drug Therapy (Chemotherapy)
07/2016 - 01/2002
4Duration of Therapy
04/2016 - 12/2008
3Injections
01/2021 - 11/2014
3Aftercare (After-Treatment)
01/2018 - 04/2012
3Intraocular Lenses (Intraocular Lens)
01/2014 - 09/2002
3Phacoemulsification
11/2012 - 03/2005